44.16
1.01%
-0.45
시간 외 거래:
44.16
Amphastar Pharmaceuticals Inc (AMPH) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
3.52%
171.84
|
178.10 | 180.56 | 145.71 | 140.02 |
Cost Of Revenue |
0.28%
81.74
|
81.97 | 72.15 | 72.97 | 66.18 |
Gross Profit |
6.28%
90.10
|
96.14 | 108.40 | 72.74 | 73.84 |
Operating Expenses
|
0.17%
42.09
|
42.16 | 35.73 | 35.84 | 40.41 |
Interest Income/Expense |
8.94%
8.611
|
9.456 | 13.70 | 3.602 | 0.398 |
Benefits Costs and Expenses |
9.36%
123.96
|
136.76 | 116.92 | 112.90 | 106.45 |
Costs And Expenses |
9.36%
123.96
|
136.76 | 116.92 | 112.90 | 106.45 |
Operating Income/Loss |
11.06%
48.01
|
53.98 | 72.68 | 36.90 | 33.43 |
Nonoperating Income/Loss |
98.94%
-0.134
|
-12.63 | -9.041 | -4.088 | 0.136 |
Income/Loss Before Equity Method Investments |
15.77%
48.45
|
41.85 | 64.03 | 33.11 | 34.35 |
Income/Loss From Equity Method Investments |
13.47%
-0.573
|
-0.505 | -0.39 | -0.301 | -0.785 |
Income/Loss From Continuing Operations Before Tax |
15.80%
47.88
|
41.34 | 63.64 | 32.81 | 33.57 |
Income Tax Expense/Benefit |
11.71%
4.126
|
4.673 | 14.03 | 6.383 | 6.752 |
Income/Loss From Continuing Operations After Tax |
19.30%
43.75
|
36.67 | 49.61 | 26.12 | 26.03 |
Net Income/Loss
|
19.38%
43.18
|
36.17 | 49.22 | 26.12 | 26.03 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
46,908%
48.21
|
-0.103 | 48.70 | 48.40 | 48.00 |
Diluted Average Shares |
1.33M%
53.01
|
0.004 | 53.92 | 53.10 | 51.97 |
Basic Earnings Per Share |
20.00%
0.90
|
0.75 | 1.01 | 0.54 | 0.54 |
Diluted Earnings Per Share |
17.39%
0.81
|
0.69 | 0.91 | 0.49 | 0.50 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):